arrow
S

Simona Pagliuca

universite de lorraine
H指数:21
被引数:1,450

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee

定义异基因造血细胞移植后骨髓增生异常/骨髓增生性肿瘤的缓解和复发,并优化移植结果:EBMT实践协调与指南委员会的建议

2026-04-010
PRE
OUTCOMES OF PATIENTS OVER 70 YEARS TREATED WITH BREXU-CEL FOR R/R MANTLE CELL LYMPHOMA: A STUDY FROM THE CTIWP OF EBMT

70岁以上接受Brexu-cel治疗复发/难治性套细胞淋巴瘤患者的疗效:EBMT CTIWP的研究

2026-03-060
OAAI
PTCy or ATG for Matched Transplantation in Myelofibrosis

为骨髓纤维化患者进行匹配移植的PTCy或ATG治疗方案

2026-02-230
OAAI
Interindividual HLA evolutionary divergence in mismatched unrelated donor allo-HCT for malignant hematological disorders

不同个体HLA在错配无关供者allo-HCT治疗恶性血液病中的进化分歧

2026-01-010
OA
Telomere content and genomics of myeloid neoplasia by WGS

端粒含量和髓系肿瘤的全基因组测序(WGS)基因组学

Blood
IF23.1
2025-09-240
OA
Optimized GMP-grade Wharton’s jelly’s mesenchymal stromal cells manufacturing and administration protocol for Graft versus Host disease prevention

优化的人源 Wharton’s jelly 间充质基质细胞 GMP 级生产与给药方案,用于移植物抗宿主病的预防

2025-09-100
PRE
TELOMERE CONTENT IN MYELOID NEOPLASIA COULD INFORM ON DIFFERENTIAL SENSITIVITY TO TELOMERASE INHIBITORS

髓系肿瘤中的端粒含量可能提示对端粒酶抑制剂的差异性敏感性

2025-09-010
PRE
Genomic and immunogenomic profiling of extramedullary acute myeloid leukemia reveals actionable clonal branching and frequent immune editing

外显性急性髓系白血病的基因组及免疫基因组分析揭示了可操作性的克隆分支和频繁的免疫编辑

2025-08-130
OAAI
Advancing the Integration of ‘Basic/Fundamental’ and Translational Cellular and Gene Therapy Science within the EBMT: Accelerating the Pathway to Progress

推进EBMT内“基础/根本”与转化细胞及基因治疗科学的整合:加速通往进步的路径

2025-08-070
PRE
CAR-T cell manufacturing failures and out-of-specification products in the real-world setting: A survey from the EBMT cellular therapy and immunobiology working party

CAR-T细胞生产失败和不符合规格的产品在真实世界环境中的情况:EBMT细胞治疗和免疫生物学工作组的一项调查

2025-05-150
PRE
Current use of donor lymphocyte infusions after allogenic stem cell transplantation in Europe: a survey on behalf of the cellular therapy and immunobiology working party of the EBMT

欧洲异基因造血干细胞移植后供者淋巴细胞输注的当前应用:代表EBMT细胞治疗与免疫生物学工作组进行的调查

2025-03-230
PRE
Differential Clinical and Immunological Impacts of Anti-T-Lymphocyte Globulin (ATLG) vs. Anti-Thymocyte Globulin (ATG) in Preventing Graft-Versus-Host Disease Post-Allogeneic Hematopoietic Stem Cell Transplantation: A Comparative Study

抗-T淋巴细胞球蛋白(ATLG)与抗胸腺细胞球蛋白(ATG)在预防异基因造血干细胞移植后移植物抗宿主病中的差异临床和免疫学影响:一项比较研究

2025-02-040
OAAI
The landscape of immune monitoring in CAR-T cell therapy: A comprehensive review and survey study by the Cellular Therapy and Immunobiology Working Party of the EBMT

CAR-T细胞治疗中的免疫监测格局:EBMT细胞治疗与免疫生物学工作组撰写的综合综述和调查研究

2025-02-010
OAAI
Clonal hematopoiesis in large granular lymphocytic leukemia
LEUKEMIA
IF13.4
2024-11-210
PRE
Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
2024-06-010
OA
Splenic irradiation for myelofibrosis prior to hematopoietic cell transplantation: A global collaborative analysis
2024-02-158
OAAI